Qiagen and Becton join to create system for DNA testing
This article was originally published in Clinica
Qiagen and Becton Dickinson plan to create the standard in preparation of DNA samples by combining Becton's sample collection expertise with Qiagen's capabilities in nucleic acid stabilisation and purification in a joint venture.
You may also be interested in...
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.
Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.